Hjem › Ulcerøs kolitt › Pennsylvania
Kliniske studier for Ulcerøs kolitt i Pennsylvania
12 studier for Ulcerøs kolitt søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- The Children's Hospital of Philadelphia /ID# 273222, Philadelphia
- Upmc Children'S Hospital Of Pittsburgh /ID# 272328, Pittsburgh
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07071519A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- og 1 flere
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RekruttererFase 3
Alder 2 til 19 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04844606A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Allegheny Health Network, Wexford
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine - Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health - Site Number: 8400107, Pittsburgh
RekruttererFase 3
Alder 16 til 80 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07184996Inflammatory Bowel Disease (IBD) Research Registry
- University of Pittsburgh Medical Center, Pittsburgh
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT04243525BOOM-IBD2 Pivotal Clinical Trial
- Pennsylvania Hospital, Philadelphia
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06571669A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06405087Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT07223424Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Allegheny Health, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 8. jan. 2026 · NCT05987852Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.